4.3 Letter

Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Simple desensitization protocol for multiple myeloma patients with lenalidomide-induced skin rash: Case series

Tomiyuki Sugi et al.

Summary: This study presents 5 cases of severe LEN-induced skin rash treated with a simple, slow desensitization protocol, with all patients successfully re-administered LEN without adverse reactions. The findings suggest that this desensitization protocol is effective in desensitizing patients without reducing the effectiveness of LEN, especially recommended for elderly patients without assistance from family members.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2021)

Article Oncology

Practical Management of Lenalidomide-Related Rash

Sara M. Tinsley et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)

Article Allergy

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

Jennifer D. Hamilton et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)